KC
ORIA

Kepos Capital’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Kepos Capital’s Portfolio ORIA Stock Details ORIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-500,000
Closed -$4.87M – 519
2022
Q2 		$4.87M Hold
500,000
– – 0.45% 93
2022
Q1 		$4.87M Hold
500,000
– – 0.37% 115
2021
Q4 		$4.88M Buy
+500,000
New +$4.91M 0.41% 103

Other funds holding ORIA

6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return

Kepos Capital's ORIA Position: Q3 2022 in Review

Kepos Capital sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q3 2022, closing a stake of 500,000 shares — an estimated $4.87M sold.

Kepos Capital first reported a position in ORIA in Q4 2021 and held it in 3 quarters. The position peaked at $4.88M in Q4 2021. 52 funds tracked by Wall St. Rank hold ORIA as of Q3 2022.

  • Kepos Capital reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q3 2022 after selling out during the quarter.
  • Kepos Capital sold 500,000 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q3 2022, an estimated $4.87M.
  • Kepos Capital first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q4 2021 and held it in 3 quarters.
  • Kepos Capital's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $4.88M in Q4 2021.
  • 52 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q3 2022.

Based on Kepos Capital's 13F filing for Q3 2022, filed 14 Nov 2022.